No Picture
Los Angeles Biotech News

California’s Life Science Industry Generates $414.2 Billion Annually

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the California life science industry, today released a new report showing California’s life science industry directly provides more than 465,000 […]

No Picture
Los Angeles Biotech News

Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced positive topline results from a U.S. pivotal nasolabial fold (NLF) study […]

Los Angeles Biotech News

Epicutis® Skincare Launches Eye Masks in Collaboration with The Exquisite Four Seasons Hotel Toronto Spa

Clean, Science-Based Skincare Elevates the Spa Experience, Spikes Spa Sales IRVINE, Calif., May 20, 2024 /PRNewswire/ — Epicutis®, a professional, medical-grade luxury skincare line by Signum Biosciences, is thrilled to announce its partnership with the […]

No Picture
Los Angeles Biotech News

Arrowhead Pharmaceuticals Presents New Clinical Data Showing ARO-RAGE Achieves High Level of Gene Knockdown in Patients with Asthma

PASADENA, Calif.–(BUSINESS WIRE)—- $arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the […]

No Picture
Los Angeles Biotech News

A new ‘rule of biology’ may have come to light, expanding insight into evolution and aging

Living things usually prefer stability to conserve energy and resources, but instability might also play a vital role, USC Dornsife molecular biologist John Tower says. Click here to view original post Click Here to Publish/Feature […]

No Picture
Los Angeles Biotech News

New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

WILMINGTON, Del.–(BUSINESS WIRE)–The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of […]

Los Angeles Biotech News

Mega startup watch; Interview with Siddhartha Mukherjee; Tracking Wegovy’s long-term effects; Biogen’s ALS flop; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]